Takayuki Matsumura
Overview
Explore the profile of Takayuki Matsumura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
832
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kotaki R, Moriyama S, Oishi S, Onodera T, Adachi Y, Sasaki E, et al.
Sci Transl Med
. 2024 Aug;
16(761):eadp9927.
PMID: 39167666
Immunological imprinting by ancestral SARS-CoV-2 strains is thought to impede the robust induction of Omicron-specific humoral responses by Omicron-based booster vaccines. Here, we analyzed the specificity and neutralization activity of...
2.
Morino E, Mine S, Tomita N, Uemura Y, Shimizu Y, Saito S, et al.
NEJM Evid
. 2024 Feb;
3(3):EVIDoa2300290.
PMID: 38411447
BACKGROUND: Vaccination against mpox (formerly known as monkeypox), an infectious disease caused by the monkeypox virus (MPXV), is needed to prevent outbreaks and consequent public health concerns. The LC16m8 vaccine,...
3.
Onodera T, Sax N, Sato T, Adachi Y, Kotaki R, Inoue T, et al.
Sci Adv
. 2023 Jun;
9(24):eadf0661.
PMID: 37315144
Severe acute respiratory syndrome coronavirus 2-neutralizing antibodies primarily target the spike receptor binding domain (RBD). However, B cell antigen receptors (BCRs) on RBD-binding memory B (B) cells have variation in...
4.
Sasaki E, Asanuma H, Momose H, Furuhata K, Mizukami T, Matsumura T, et al.
Mucosal Immunol
. 2023 Mar;
16(3):275-286.
PMID: 36935091
The stimulation of local immunity by vaccination is desirable for controlling virus replication in the respiratory tract. However, the local immune stimulatory effects of adjuvanted vaccines administered through the non-mucosal...
5.
Takano T, Sato T, Kotaki R, Moriyama S, Fukushi S, Shinoda M, et al.
Nat Commun
. 2023 Mar;
14(1):1451.
PMID: 36922492
The immunogenicity of mRNA vaccines has not been well studied when compared to different vaccine modalities in the context of additional boosters. Here we show that longitudinal analysis reveals more...
6.
Kashima Y, Mizutani T, Nakayama-Hosoya K, Moriyama S, Matsumura T, Yoshimura Y, et al.
Sci Rep
. 2023 Feb;
13(1):1935.
PMID: 36732528
SARS-CoV-2 continues to spread worldwide. Patients with COVID-19 show distinct clinical symptoms. Although many studies have reported various causes for the diversity of symptoms, the underlying mechanisms are not fully...
7.
Matsumura T, Takano T, Takahashi Y
Int Immunol
. 2022 Dec;
35(5):213-220.
PMID: 36566501
Vaccination for the prevention of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection is considered the most promising approach to control the pandemic of coronavirus disease 2019 (COVID-19). Although...
8.
Terahara K, Sato T, Adachi Y, Tonouchi K, Onodera T, Moriyama S, et al.
iScience
. 2022 Aug;
25(9):104959.
PMID: 35992306
Determinants of memory T cell longevity following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remain unknown. In addition, phenotypes associated with memory T cell longevity, antibody titers, and disease...
9.
Takano T, Morikawa M, Adachi Y, Kabasawa K, Sax N, Moriyama S, et al.
Cell Rep Med
. 2022 May;
3(5):100631.
PMID: 35545084
Two doses of Pfizer/BioNTech BNT162b2 mRNA vaccine elicit robust severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing antibodies with frequent adverse events. Here, by applying a high-dimensional immune profiling on 92...
10.
Shinada K, Sato T, Moriyama S, Adachi Y, Shinoda M, Ota S, et al.
Viruses
. 2022 Apr;
14(4).
PMID: 35458400
The effect of treatment with favipiravir, an antiviral purine nucleoside analog, for coronavirus disease 2019 (COVID-19) on the production and duration of neutralizing antibodies for SARS-CoV-2 was explored. There were...